Robert Peabody comments on the recent sentence of Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug in "Cambridge pharmaceutical company ordered to pay $7.2 million in restitution," published by the Boston Globe.
Subscription may be required to view article
Read Article at The Boston Globe